KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 103 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | +300.0% | 350 | +483.3% | 0.00% | – |
| Q2 2022 | $1,000 | – | 60 | +300.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 15 | -99.1% | 0.00% | -100.0% |
| Q4 2021 | $20,000 | -4.8% | 1,689 | -6.8% | 0.00% | 0.0% |
| Q3 2021 | $21,000 | -69.1% | 1,813 | -32.4% | 0.00% | -87.5% |
| Q2 2020 | $68,000 | +3300.0% | 2,680 | +2190.6% | 0.01% | +700.0% |
| Q1 2020 | $2,000 | -33.3% | 117 | -60.6% | 0.00% | 0.0% |
| Q4 2019 | $3,000 | 0.0% | 297 | -15.6% | 0.00% | 0.0% |
| Q3 2019 | $3,000 | -76.9% | 352 | -64.2% | 0.00% | -75.0% |
| Q2 2019 | $13,000 | +160.0% | 983 | +275.2% | 0.00% | +100.0% |
| Q2 2018 | $5,000 | – | 262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |